SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2025

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 7 – SUBSEQUENT EVENTS

Subsequent to the period on October 7, 2025 as part of the definitive Agreement entered into on August 1, 2025 by AI Technology Group Inc. (refer Note 5), which included Biomed360 Solutions Corp., the Company issued 27,958,695 restricted common shares to the shareholders of Biomed360 Solutions Corp.  No shares have been issued to AVM Biotechnology Inc. (“AVM”). The agreement also requires AI to provide certain convertible loans to AVM over the next several months prior to closing.  Closing of this proposed transaction is subject to a number of conditions customary for transactions of this type. There is no assurance that this transaction will close.

The Company has evaluated subsequent events through September 10, 2025 which is the date the financial statements were available to be issued. The Company had invoices paid on behalf of the Company by its president subsequent to the period of $18,996. Total amount owing to the Company’s president as of November 14, 2025 is $80,299.  The amounts due to related party are unsecured and non- interest-bearing with no set terms of repayment.